Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials
![]() |
Novartis (Source: Novartis International AG | 6 years ago) |
Link |
![]() |
To download a copy of the MalaFA report (Source: Novartis International AG | 6 years ago) |
Link |
![]() |
iCCM Key Strategy (Source: Novartis International AG | 6 years ago) |
Link |
![]() |
For more information on our work in malaria (Source: Novartis International AG | 6 years ago) |
Link |
![]() |
Malaria Summit of the Commonwealth Heads of Government (Source: Novartis International AG | 6 years ago) |
Link |
![]() |
Vas Narasimhan, CEO of Novartis, LinkedIn (Source: Novartis International AG | 6 years ago) |
Link |
![]() |
Story - Meet Martin Grobusch, malaria fighter (Source: Novartis International AG | 6 years ago) |
Link |
![]() |
Story - Malaria is still disrupting lives, despite progress (Source: Novartis International AG | 6 years ago) |
Link |
![]() |
Story - Researchers overcome hurdles to test experimental malaria drug (Source: Novartis International AG | 6 years ago) |
Link |